^
Association details:
| Biomarker: | CARS1‐ALK fusion |
|---|---|
| Cancer: | Sarcoma |
| Drug: | Alecensa (alectinib) (ALK inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis
Published date:
09/30/2020
Excerpt:
...a case of advanced metastatic low‐grade sarcoma...The patient was detected to have CARS‐ALK fusion by NGS...the patient has been responding well to the second‐line ALK tyrosine kinase inhibitor alectinib to date.
DOI:
10.1002/ONCO.13543
